The World Health Organization (WHO) has added the first molecular diagnostic test for Ebola Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL). According to reports, the test detects BDBV by identifying the virus’s genetic material in blood samples, enabling faster and more accurate confirmation of infection.
Multiple outlets describe the decision as a step to improve diagnosis during ongoing BDBV-related outbreaks in Central and East Africa, particularly in the Democratic Republic of Congo and Uganda. The Times of India notes that the change is significant because treatments used for the Zaire Ebola strain are not effective against Bundibugyo virus, increasing the importance of correctly identifying the specific Ebola type causing illness. It also references the situation on the ground, including the reported scale of cases in the Democratic Republic of Congo and signs of containment efforts in Uganda.
All sources agree on WHO’s action to authorize the new diagnostic test for emergency settings and the test’s molecular approach for confirming BDBV infection.
